Janzon, M <br/><br/>
Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease.  [electronic resource] 

 -  European heart journal  Jan 2002 
 - 31-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0195-668X 
<br/><br/><label>Standard No.: </label>10.1053/euhj.2001.2695  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Ambulatory Care--economics<br/>Coronary Artery Disease--complications<br/>Cost-Benefit Analysis--economics<br/>Electrocardiography--economics<br/>Endpoint Determination<br/>Female<br/>Fibrinolytic Agents--economics<br/>Follow-Up Studies<br/>Health Care Costs<br/>Hospitalization--economics<br/>Humans<br/>Male<br/>Myocardial Infarction--complications<br/>Platelet Glycoprotein GPIIb-IIIa Complex--economics<br/>Prospective Studies<br/>Scandinavian and Nordic Countries--epidemiology<br/>Sensitivity and Specificity<br/>Survival Analysis<br/>Ventricular Function, Left--physiology